🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
ZBH
NYSE
🇺🇸 US
Zimmer Biomet Holdings
Healthcare
26Score
DipBuster Score™
$94.86
$1.14 (-1.19%)
Live price · Source: Yahoo
52-Week Position
$79.12
63% of range
$104.15
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
BetaN/A
52W High$104.15
52W Low$79.12
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (63% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position63% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta—
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Zimmer Biomet Holdings (ZBH), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-10-01 | Campbell Gary Craig | SELL | 1,218 |
| 2026-10-01 | Campbell Gary Craig | SELL | 2,368 |
| 2026-10-01 | Campbell Gary Craig | SELL | 480 |
| 2026-10-01 | Campbell Gary Craig | BUY | 1,218 |
| 2026-10-01 | Campbell Gary Craig | SELL | 932 |
| 2026-10-01 | Campbell Gary Craig | BUY | 2,368 |
| 2026-09-30 | Shapiro Louis | BUY | 153 |
| 2026-09-30 | Kurdikar Devdatt | BUY | 174 |
| 2026-09-30 | Kolli Sreelakshmi | BUY | 174 |
| 2026-09-30 | Hilado Maria Teresa | BUY | 376 |
Valuation
P/E RatioN/A
Market CapN/A
BetaN/A
Dividend/yrNone
52W High$104.15
52W Low$79.12
52-Week Range
$79.12Now$104.15
63% through annual range
From 52W High−8.9%
From 52W Low+19.9%
📖 Plain English Summary
Zimmer Biomet Holdings is at 63% of its 52-week range.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for ZBH
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — ZBH
Heuristic · balance sheet, insider filings, price data, academic research
Zimmer Biomet Holdings — DipBuster Score 26/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Zimmer Biomet Holdings free
Add ZBH to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
15/25
Momentum & Volume
6/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
10
/100 · NEUTRAL
dip depth
10/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 26/100
📊
Run a full check in the AI analysis tab for a deeper look.